The Doctor’s Dose
AMD OpenAI Partnership
AMD OpenAI Partnership: What the Deal Means for AMD Stock TraderInsight • September 2025 • Chip Stocks, AI, Trading Shares of **AMD** ripped on Monday after the company announced a long-term deal to supply OpenAI with GPUs across a 6-gigawatt deployment. The **AMD...
AI Jobs Impact
AI Jobs Impact: What Yale and Brookings Say About Generative AI’s Effect on Employment TraderInsight • September 2025 • Labor, AI, Trading A new study from Yale University’s Budget Lab and the Brookings Institution finds that the AI jobs impact has been modest so far....
US Government Shutdown and Jobs Data
US Government Shutdown and Jobs Data Shock Markets: What Traders Should Watch TraderInsight • September 2025 • Macro, Jobs, Trading The US government shutdown and jobs data are rattling Wall Street. ADP reported a surprise loss of 32,000 private-sector jobs — the...
Weak U.S. Job Market Flashes in ADP Data
Weak U.S. Job Market Flashes in ADP Data: What Traders Need to Know October 2025 • Jobs, Fed, Trading The weak U.S. job market was evident again in the ADP data, which showed a loss of 32,000 private-sector jobs in September, contrary to forecasts for a gain of...
Caterpillar Stock Outlook
Caterpillar Stock Outlook: Rate Cuts, AI Power, and a Technical Setup TraderInsight • September 2025 • Industrials, AI, Rate Cuts After lagging earlier in the year, Caterpillar's stock outlook has turned sharply higher. Shares are up 22% in the past three months as...
Scaling Into Trades
Smarter Lot Sizing: How Scaling Into Trades Improves Consistency One of the most overlooked skills in trading is scaling into trades. Many traders either go all-in at their first entry point or wait too long, missing the best opportunities. But by learning how to...
Trading Psychology and Premature Entries
The Psychology of Jumping the Gun in Trading A friend and fellow trader called me on Monday and asked me to look at the chart of Robin Hood (HOOD) and “explain why the short was losing money.” I responded as I have many times in the past: if it were me, I would be...
US Pharma Tariff Cap
US Pharma Tariff Cap: Relief for Drugmakers Amid Trump’s Trade Moves TraderInsight • September 27, 2025 • Pharma, Policy, Tariffs The Trump administration will honour a US pharma tariff cap of 15% on imports from the EU and Japan — far below the 100% levy initially...
Regret vs Disappointment: Trading Psychology Solutions
Every trader knows the sting of a trade gone wrong—but did you know that not all negative emotions are created equal? Performance psychology research highlights two powerful, yet distinct, responses to trading outcomes: regret vs disappointment. Understanding the...
The U.S. Soybean Trade Crisis
The U.S. soybean trade crisis: Market Shifts, Risks, and Opportunities The U.S. soybean trade crisis is deepening as China—historically the dominant buyer of American soybeans—has effectively halted imports just as the fall harvest ramps up. Government data indicate...
Conquering FOMO in Trading: A Performance Psychology Perspective
Conquering FOMO in Trading: A Performance Psychology Perspective Conquering FOMO is one of the biggest challenges traders face on their path to consistent performance. Fear of Missing Out (FOMO) can appear as a simple emotional nudge, but research in performance...
Nvidia AI Backstop
Nvidia AI Backstop: How $100 Billion Fuels the Next Leg of the Boom TraderInsight • September 2025 • NVDA, AI, Circular Financing Nvidia has turned its free cash flow machine into a war chest for AI. By acting as an Nvidia AI backstop, the company is funneling...
AstraZeneca Drug Discounts
AstraZeneca Drug Discounts Show Pharma’s Response to Trump’s Pressure TraderInsight • September 26, 2025 • Pharma, Pricing, Policy With a Trump administration deadline looming, AstraZeneca announced it will cut prices on key asthma and diabetes drugs by as much as...
Drug Pricing Uncertainty
Drug Pricing Uncertainty Keeps a Lid on Pharma Stocks TraderInsight • September 2025 • Pharma, Tariffs, Policy The Trump administration’s 100% tariffs on foreign-made drugs sounded harsh. In reality, Big Pharma can live with them. What the sector can’t shake is drug...
Perpetual Futures Trading
Perpetual Futures Trading: Why ‘Perps’ Are Driving a New Speculation Boom TraderInsight • September 2025 • Crypto, Leverage, Derivatives Crypto traders are rushing into perpetual futures trading, contracts known as “perps” that allow investors to apply leverage of 10,...
Day Trading Margin Rule Change
Day Trading Margin Rule Change: What It Means for Retail Traders TraderInsight • September 24, 2025 • FINRA, SEC, PDT For over two decades, retail traders have been operating under the shadow of the Pattern Day Trader rule. If your account dropped below $25,000, you...
Alibaba AI Spending Rally
Alibaba AI Spending Rally: Why the Stock Could Climb Even Higher TraderInsight • September 24, 2025 • BABA, AI, China Tech Alibaba (BABA) shares jumped 10% after the company announced new AI spending, overseas data centers, and the unveiling of Qwen3-Max, its...
Nvidia AI Backstop
Nvidia AI Backstop: Trader’s Playbook for the AI Ecosystem TraderInsight • September 2025 • NVDA, AI Infrastructure, Market Strategy Nvidia’s $100 billion deal with OpenAI reinforces its role as the Nvidia AI backstop — a financing partner to secure chip demand and...
Stock Market Overvaluation
Is the Stock Market Overvalued? What Traders Should Watch Next TraderInsight • September 22, 2025 • S&P 500, Fed, Valuations The S&P 500 has set 28 record highs this year and sits near 6,664. But valuations are stretched to dot-com era levels, making many...
Powell Speech Market Selloff
Powell Speech Market Selloff: Why Stocks Dropped After Fed Remarks TraderInsight • Today • Federal Reserve, Markets, Equities Stocks fell sharply today after Federal Reserve Chairman Jerome Powell delivered a speech that rattled investor confidence. The Powell speech...